BeiGene Non Current Liabilities Other vs Total Assets Analysis

688235 Stock

176.00 0.32 0.18%

BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Non Current Liabilities Other and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

Non Current Liabilities Other vs Total Assets

Non Current Liabilities Other vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Non Current Liabilities Other account and Total Assets. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between BeiGene's Non Current Liabilities Other and Total Assets is -0.67. Overlapping area represents the amount of variation of Non Current Liabilities Other that can explain the historical movement of Total Assets in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Non Current Liabilities Other and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Other of BeiGene are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Current Liabilities Other i.e., BeiGene's Non Current Liabilities Other and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.67

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Non Current Liabilities Other

Total Assets

Total assets refers to the total amount of BeiGene assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in BeiGene books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.As of November 29, 2024, Tax Provision is expected to decline to about 29.8 M. In addition to that, Selling General Administrative is expected to decline to about 1 B

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.6B	3.2B	3.7B	2.8B
Cost Of Revenue	164.9M	286.5M	379.9M	304.1M

Total Operating Expenses Cost Of Revenue

BeiGene fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Non Current Liabilities Other	Net Working Capital	Intangible Assets	Other Current Liab	Property Plant And Equipment Net	Long Term Investments
Total Assets		0.96	1.0	-0.84	0.94	0.95	0.8	0.97	-0.87	0.84	-0.43	0.97	0.51	0.94	0.94	0.84	0.98	1.0	1.0	0.93	-0.67	0.97	0.88	-0.57	0.69	0.9
Total Current Liabilities	0.96		0.93	-0.93	0.99	0.95	0.94	0.94	-0.86	0.85	-0.54	0.99	0.33	0.81	0.85	0.96	0.99	0.95	0.92	1.0	-0.81	0.86	0.94	-0.76	0.86	0.92
Total Stockholder Equity	1.0	0.93		-0.81	0.91	0.94	0.76	0.97	-0.85	0.83	-0.4	0.95	0.55	0.96	0.95	0.8	0.97	1.0	1.0	0.9	-0.64	0.99	0.85	-0.51	0.64	0.89
Retained Earnings	-0.84	-0.93	-0.81		-0.95	-0.88	-0.95	-0.83	0.86	-0.74	0.75	-0.94	-0.04	-0.65	-0.77	-0.94	-0.9	-0.83	-0.79	-0.95	0.92	-0.71	-0.92	0.87	-0.93	-0.91
Accounts Payable	0.94	0.99	0.91	-0.95		0.93	0.95	0.94	-0.87	0.78	-0.56	0.99	0.3	0.78	0.83	0.95	0.98	0.93	0.9	1.0	-0.83	0.83	0.92	-0.77	0.88	0.9
Cash	0.95	0.95	0.94	-0.88	0.93		0.86	0.88	-0.75	0.89	-0.43	0.94	0.28	0.82	0.96	0.9	0.95	0.95	0.93	0.92	-0.83	0.89	0.96	-0.62	0.78	0.98
Non Current Assets Total	0.8	0.94	0.76	-0.95	0.95	0.86		0.79	-0.74	0.77	-0.61	0.91	0.03	0.57	0.69	0.99	0.89	0.79	0.74	0.96	-0.92	0.64	0.94	-0.9	0.98	0.88
Non Currrent Assets Other	0.97	0.94	0.97	-0.83	0.94	0.88	0.79		-0.92	0.71	-0.44	0.97	0.58	0.92	0.86	0.81	0.97	0.97	0.97	0.93	-0.62	0.94	0.8	-0.56	0.67	0.81
Long Term Debt	-0.87	-0.86	-0.85	0.86	-0.87	-0.75	-0.74	-0.92		-0.62	0.72	-0.9	-0.42	-0.83	-0.73	-0.74	-0.88	-0.86	-0.85	-0.87	0.59	-0.82	-0.71	0.68	-0.66	-0.73
Net Receivables	0.84	0.85	0.83	-0.74	0.78	0.89	0.77	0.71	-0.62		-0.45	0.79	0.2	0.74	0.82	0.83	0.85	0.84	0.82	0.81	-0.71	0.78	0.92	-0.65	0.72	0.91
Good Will	-0.43	-0.54	-0.4	0.75	-0.56	-0.43	-0.61	-0.44	0.72	-0.45		-0.55	0.28	-0.33	-0.36	-0.58	-0.51	-0.43	-0.39	-0.57	0.63	-0.32	-0.56	0.84	-0.68	-0.56
Common Stock Shares Outstanding	0.97	0.99	0.95	-0.94	0.99	0.94	0.91	0.97	-0.9	0.79	-0.55		0.37	0.84	0.88	0.92	0.99	0.96	0.94	0.99	-0.79	0.89	0.91	-0.72	0.82	0.91
Short Term Investments	0.51	0.33	0.55	-0.04	0.3	0.28	0.03	0.58	-0.42	0.2	0.28	0.37		0.7	0.39	0.07	0.42	0.53	0.58	0.3	0.25	0.64	0.08	0.25	-0.16	0.11
Non Current Liabilities Total	0.94	0.81	0.96	-0.65	0.78	0.82	0.57	0.92	-0.83	0.74	-0.33	0.84	0.7		0.89	0.62	0.88	0.95	0.97	0.77	-0.4	0.99	0.69	-0.34	0.42	0.75
Capital Lease Obligations	0.94	0.85	0.95	-0.77	0.83	0.96	0.69	0.86	-0.73	0.82	-0.36	0.88	0.39	0.89		0.75	0.89	0.94	0.94	0.81	-0.68	0.94	0.85	-0.43	0.59	0.92
Inventory	0.84	0.96	0.8	-0.94	0.95	0.9	0.99	0.81	-0.74	0.83	-0.58	0.92	0.07	0.62	0.75		0.92	0.83	0.79	0.96	-0.92	0.7	0.97	-0.86	0.96	0.92
Total Liab	0.98	0.99	0.97	-0.9	0.98	0.95	0.89	0.97	-0.88	0.85	-0.51	0.99	0.42	0.88	0.89	0.92		0.98	0.96	0.98	-0.75	0.92	0.92	-0.7	0.8	0.92
Net Invested Capital	1.0	0.95	1.0	-0.83	0.93	0.95	0.79	0.97	-0.86	0.84	-0.43	0.96	0.53	0.95	0.94	0.83	0.98		1.0	0.93	-0.66	0.98	0.87	-0.56	0.68	0.9
Total Current Assets	1.0	0.92	1.0	-0.79	0.9	0.93	0.74	0.97	-0.85	0.82	-0.39	0.94	0.58	0.97	0.94	0.79	0.96	1.0		0.89	-0.61	0.99	0.83	-0.49	0.61	0.87
Capital Stock	0.93	1.0	0.9	-0.95	1.0	0.92	0.96	0.93	-0.87	0.81	-0.57	0.99	0.3	0.77	0.81	0.96	0.98	0.93	0.89		-0.82	0.83	0.93	-0.8	0.89	0.9
Non Current Liabilities Other	-0.67	-0.81	-0.64	0.92	-0.83	-0.83	-0.92	-0.62	0.59	-0.71	0.63	-0.79	0.25	-0.4	-0.68	-0.92	-0.75	-0.66	-0.61	-0.82		-0.51	-0.91	0.84	-0.95	-0.89
Net Working Capital	0.97	0.86	0.99	-0.71	0.83	0.89	0.64	0.94	-0.82	0.78	-0.32	0.89	0.64	0.99	0.94	0.7	0.92	0.98	0.99	0.83	-0.51		0.77	-0.38	0.5	0.82
Intangible Assets	0.88	0.94	0.85	-0.92	0.92	0.96	0.94	0.8	-0.71	0.92	-0.56	0.91	0.08	0.69	0.85	0.97	0.92	0.87	0.83	0.93	-0.91	0.77		-0.79	0.9	0.98
Other Current Liab	-0.57	-0.76	-0.51	0.87	-0.77	-0.62	-0.9	-0.56	0.68	-0.65	0.84	-0.72	0.25	-0.34	-0.43	-0.86	-0.7	-0.56	-0.49	-0.8	0.84	-0.38	-0.79		-0.94	-0.71
Property Plant And Equipment Net	0.69	0.86	0.64	-0.93	0.88	0.78	0.98	0.67	-0.66	0.72	-0.68	0.82	-0.16	0.42	0.59	0.96	0.8	0.68	0.61	0.89	-0.95	0.5	0.9	-0.94		0.83
Long Term Investments	0.9	0.92	0.89	-0.91	0.9	0.98	0.88	0.81	-0.73	0.91	-0.56	0.91	0.11	0.75	0.92	0.92	0.92	0.9	0.87	0.9	-0.89	0.82	0.98	-0.71	0.83

Click cells to compare fundamentals

BeiGene Account Relationship Matchups

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:

How To Invest In BeiGene

Details

Is BeiGene Stock a good investment?

Details

What is BeiGene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BeiGene Non Current Liabilities Other vs Total Assets Analysis

Non Current Liabilities Other vs Total Assets

Non Current Liabilities Other vs Total Assets Correlation Analysis

Correlation Coefficient

Non Current Liabilities Other

Total Assets

BeiGene fundamental ratios Correlations

BeiGene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Capital Stock	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity

Property Plant And Equipment Net	- 0.95	Non Current Liabilities Other
Capital Stock	- 0.95	Retained Earnings
Non Current Assets Total	- 0.95	Retained Earnings
Accounts Payable	- 0.95	Retained Earnings
Property Plant And Equipment Net	- 0.94	Other Current Liab
Inventory	- 0.94	Retained Earnings